Sun, P., Cen, H., Yang, H., Huang, R., Cai, Z., Gu, X., . . . Li, Z. PI3Kδ inhibitor linperlisib combined with gemcitabine and oxaliplatin for relapsed or refractory diffuse large B-cell lymphoma: A multicenter, single-arm phase Ib/II trial. BMC.
Chicago Style (17th ed.) CitationSun, Peng, et al. PI3Kδ Inhibitor Linperlisib Combined with Gemcitabine and Oxaliplatin for Relapsed or Refractory Diffuse Large B-cell Lymphoma: A Multicenter, Single-arm Phase Ib/II Trial. BMC.
MLA (9th ed.) CitationSun, Peng, et al. PI3Kδ Inhibitor Linperlisib Combined with Gemcitabine and Oxaliplatin for Relapsed or Refractory Diffuse Large B-cell Lymphoma: A Multicenter, Single-arm Phase Ib/II Trial. BMC.
Warning: These citations may not always be 100% accurate.